MoonLake Immunotherapeutics (MLTX)
$53.85 $0.87 (1.65%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$3.43B -
Day's Range
$51.55 - $53.82 -
Volume
170,003 -
52 Week Low / High
$37.55 - $64.98 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 11
- Strong Buy
- 2
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $63.27
- Target Price
Company News
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Is MoonLake Immunotherapeutics (MLTX) the Best Guru Stock To Buy Now? — Sep 25th, 2024
We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where MoonLake Immunotherapeutics (NASDAQ:MLTX) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that ...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Is MoonLake Immunotherapeutics (MLTX) the Best Guru Stock To Buy Now? — Sep 25th, 2024
We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where MoonLake Immunotherapeutics (NASDAQ:MLTX) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that ...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
-
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics — Oct 9th, 2024
Overview of Recent Transaction On October 4, 2024, Biotechnology Value Fund L.P. executed a significant transaction involving the shares of MoonLake Immunotherapeutics (NASDAQ:MLTX). The firm reduced its holdings by 2,000,000 shares, which resulted in a 9.19% decrease in their previous st...
Similar Stocks
Portfolio
Comprised of 1 portfolios